Arabic Arabic English English French French German German
dark

EchelonDx and Cradle Genomics Join Forces to Accelerate Development of Comprehensive Non-Invasive Prenatal Diagnostic Products

Echelon Diagnostics, Inc., a leading provider of genomic healthcare AI imaging analysis and big data solutions, and Cradle Genomics, Inc., inventors of a novel prenatal testing methodology, today announced an agreement that will help accelerate the development of Cradle’s innovative cellular-based non-invasive prenatal diagnosic (NIPD) products. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Study: Algae-Derived Nasal Spray Effective in Reducing COVID Infection Among ICU Staff

Next Post

Tetra Bio-Pharma Granted a Drug Establishment License to Distribute REDUVO Soft Gel Capsules in Canada

Related Posts
Total
0
Share